Yichang HEC Changjiang Pharmaceutical Co., Ltd. (1558)

Overview

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry in the People's Republic of China, specializing in the development, manufacture, and sale of a wide range of pharmaceutical products. With a focus on therapeutic areas such as anti-virus, endocrine and metabolic diseases, cardiovascular diseases, and anti-infection diseases, the company has established itself as a key supplier of essential medicines and healthcare solutions. Its portfolio includes both active pharmaceutical ingredients (APIs) and a variety of finished drug products.

The company leverages its substantial research and development capabilities to innovate in the field of pharmaceuticals, medical devices, and biotechnology, continually expanding its offerings to meet the healthcare needs of the population. Additionally, YiChang HEC ChangJiang Pharmaceutical extends medical consulting services, supporting healthcare professionals and institutions in delivering effective patient care.

YiChang HEC ChangJiang Pharmaceutical markets its products primarily to hospitals and medical institutions across China, utilizing a comprehensive network of distributors to ensure wide reach and availability. The company has secured strategic agreements with notable entities like Jointown Pharmaceutical Group Co., Ltd., and China National Accord Medicines Corporation Ltd., further strengthening its position in the market. Initially founded as Yichang Changjiang Pharmaceutical Company Limited, it underwent a rebranding to its current name in May 2015. Operating as a subsidiary under Sunshine Lake Pharma Co., Ltd., YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is headquartered in Yichang, China, bringing innovative healthcare solutions since its inception in 2001.

Products and Services

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. offers a comprehensive range of products and services designed to meet the diverse needs of the healthcare sector:

• Anti-Viral Medications: A leading line of products, catering to the prevention and treatment of viral infections. These are crucial in managing and controlling outbreaks of viral diseases, contributing significantly to public health.
• Endocrine and Metabolic Disease Treatments: Specialized pharmaceuticals aimed at managing conditions such as diabetes, thyroid disorders, and other metabolic syndromes, these treatments help patients maintain their health and quality of life.
• Cardiovascular Disease Medications: Medications developed for the prevention and treatment of diseases affecting the heart and blood vessels. These products are integral to combating one of the leading causes of mortality worldwide.
• Anti-Infection Drugs: A broad spectrum of antibiotics and related medications that play a key role in fighting bacterial, fungal, and other types of infections, ensuring patients' recovery and preventing the spread of diseases.
• Active Pharmaceutical Ingredients (APIs): YiChang HEC ChangJiang Pharmaceutical also manufacturs and supplies APIs, the essential components for drug manufacturing, allowing for the creation of various pharmaceutical formulations.
• Research and Development: The company's investment in R&D enables the continuous improvement of existing products and the development of new, innovative solutions in pharmaceuticals, medical devices, and biotechnology.
• Medical Consulting Services: Beyond product offerings, YiChang HEC ChangJiang provides expert medical consulting services, supporting healthcare institutions and professionals in optimizing patient care protocols and procedures.